PRM77 DO EQ-5D AND SF-6D ask the right questions in mental health? a content validation using interviews with patients  by Brazier, J.E. et al.
A194  VA L U E  I N  H E A LT H  1 7  ( 2 0 1 4 )  A 1 - A 2 9 5  
Objectives: The purpose of this study was to the assess construct validity of the 
World Health Organization’s Quality of Life-BREF (WHOQOL-BREF) instrument among 
adults with autism. Reliability and floor and ceiling effects of the WHOQOL-BREF 
instrument in this population were also assessed. MethOds: A cross-sectional 
online survey (using Qualtrics survey system) of adults with autism enrolled with the 
Interactive Autism Network (IAN) was performed for study purposes. Among adults 
with autism registered with the IAN, those aged 18 years and above and having the 
capacity to self-report with little or no proxy help were identified and targeted for the 
study. The proposed structure of the WHOQOL-BREF instrument was validated using 
confirmatory factor analysis. Convergent and discriminant validity was assessed 
based on relevant item-total correlation. Known-groups validity was tested by com-
paring WHOQOL-BREF scores among group differing in autism severity. Cronbach’s 
alpha was used to assess internal consistency reliability. Floor and ceiling effects were 
determined based on percentage (≥ 15%) of responses with lowest and highest pos-
sible score on the instrument, respectively. Results: The final sample included 262 
adults with autism. Based on the CFA analysis, the second-order hierarchical model of 
WHOQOL-BREF instrument was considered the best fitting model among adults with 
autism (chi-square= 428.00, df= 242; RMSEA= 0.054; CFI= 0.091). Corrected item-total 
correlation suggested good convergent and discriminant validity of the WHOQOL-
BREF instrument. Scores for the physical and psychological domains of the WHOQOL-
BREF varied significantly by autism severity, indicating adequate known-groups 
validity. High internal consistency reliability (Cronbach’s alpha 0.914) was observed. 
The floor and ceiling effect are acceptable with the exception of one item which 
displayed floor effect and six items which displayed ceiling effects. cOnclusiOns: 
Study results indicated that the WHOQOL-BREF is a psychometrically sound instru-
ment to assess quality of life among adults with autism.
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Objectives: The objective was to examine the content of EQ-5D and SF-6D against 
what individuals with mental health problems perceive to be important to their 
quality of life using rigorous qualitative methods. MethOds: We first undertook 
a systematic review of qualitative research undertaken with people with mental 
health problems. This review provided the basis for the topic guide used in semi 
structured in-depth interviews undertaken with 19 people who had a broad range 
of mental health problems at varying levels of severity drawn from primary and 
secondary care services (including mood disorders and psychosis) in the UK. The 
interviews were analysed thematically using framework analysis. Results: A 
framework analysis of 13 qualitative studies revealed six major themes: well-being 
and ill-being; control, autonomy and choice; self-perception; belonging; activity; and 
hope. Despite widening the types and severity of mental health problems studied, 
our interview data fitted well with the themes from the review, any differences 
tended to be within the themes and related to the degree of impact of the themes 
on different levels of severity, chronicity and diagnosis. Physical health was also 
found to be more important amongst the interviewees, so it was added as a seventh 
theme as opposed to a minor sub-theme in the review. cOnclusiOns: The review 
of qualitative research and our own interviews raises important questions about 
the content validity of the EQ-5D and SF-6D in mental health. While well-being and 
ill-being are partly covered by dimensions like ‘depression and anxiety’ and ‘feel-
ing downhearted and low’, this leaves out other important aspects such as control, 
autonomy and choice; self-perception; belonging (to society); and hope.
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Objectives: The Charlson Comorbidity Index (CCI), although intended to predict 
mortality risk, is widely used as a means of controlling for comorbidities. Charlson et al. 
(2008; CCI2008) added items to better predict resource use and alternatively Quan et al. 
(2011; CCI2011) removed or updated the weighting of comorbidities to reflect modern 
estimates of contributions to mortality risk. The current study assessed the predictive 
utility of these three CCI variants across categories of health outcomes. MethOds: 
Data were analyzed from the 2013 U.S. National Health and Wellness Survey (n= 75,000), 
an annual, cross-sectional, general health survey of adults (aged ≥ 18). CCI scores were 
calculated from a weighted sum of self-reported diagnoses. Health outcomes included: 
health-related quality of life measured via the SF-36v2 (mental and physical health 
status, and health utilities); Work Productivity and Activity Impairment (WPAI-GH) 
questionnaire-based measures; and resource use (visits to the emergency room, 
hospital, and traditional providers in the last 6 months). CCI scores were correlated 
with health outcomes (Pearson correlations for HRQoL, Spearman’s rho for WPAI-GH 
and resource use). Results: All correlations were significant, p< .001, with higher 
CCI scores associated with worse outcomes. CCI, CCI2008, and CCI2011 correlations 
ranged from lows of -.06, -.20, and -.07, respectively (with mental health status), to 
-.34, -.37, and -.30 (with physical health status), .27, .36, and .24 (with activity impair-
ment), and .33, .39, and .25 (with provider visits). cOnclusiOns: Across all outcomes, 
CCI2008 exhibited the strongest correlations, with the original CCI exhibiting slightly 
higher correlations than CCI2011 in all but two cases. The utility of the CCI depends 
on variance explained in the outcomes plus the anticipated independence of included 
comorbidities vis-à-vis predictors of interest in multivariable models.
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PFS analysis of BOLERO-2 trial. Afterwards, we fitted parametric models to the recon-
structed IPD in the statistical package Stata. Both statistical and graphical tests 
were conducted to verify the relative and absolute validity of the findings. Finally, 
the equations for transition probabilities were derived using the general equation 
for transition probabilities used in model-based economic evaluations, and the 
parameters were estimated from fitted distributions. Results: The results of the 
application of the tutorial suggest that the log-logistic model best fits the recon-
structed data from the latest published KM curves of the BOLERO-2 trial. Results 
from the regression analyses were confirmed graphically. An equation for transition 
probabilities was obtained for each arm of the BOLERO-2 trial. cOnclusiOns: In 
this paper, a tutorial was proposed and used to estimate the transition probabilities 
for model-based economic evaluation, based on the results of the final PFS analy-
sis of the BOLERO-2 trial in mBC. These results can serve as a basis for any model 
(Markov) that needs the parameterization of transition probabilities, and only has 
summary Kaplan-Meier plots available.
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Objectives: Increasingly, economic evaluations of progressive diseases have 
adopted the approach of partitioned survival analysis. In three state cancer mod-
els (pre-progression, post-progression and death) the proportion of patients in each 
state are often obtained from survival functions for progression free (PFS) and over-
all survival (OS). The proportion in the pre-progression state is estimated from the 
PFS curve and the proportion in the post-progression state is the difference between 
OS and PFS. Based on simulated data reflecting the results from recent randomized 
clinical trials, this study explored the accuracy of this method. MethOds: Three 
clinical scenarios were considered based on varying OS. Clinical trial data sets were 
simulated for a standard and a novel treatment assuming substantive benefit with 
the new treatment in terms of slowing progression but no impact of treatment on 
mortality rates within health states. Costs and utility values for each state were 
assumed and represent plausible values. Analysis identified the difference between 
actual results based on complete follow up and results based on curtailed follow up 
of various durations using both traditional Markov modelling and partitioned sur-
vival analysis. Results: In the moderate survival scenario (median OS ~12 months), 
the ICUR for the new treatment based on the raw simulated data was $119,600. 
With trial follow up of 9 months the ICUR for new treatment was $120,600 with 
Markov modelling and $87,500 with partitioned survival analysis. With 18 months 
follow up, the figures were $122,500 and $103,000 respectively. Results with different 
durations of follow up found a consistent pattern as did results for both the short 
and long term survival scenarios. cOnclusiOns: Analyses based on partitioned 
survival analysis have an inherent bias in favour of treatments which impact disease 
progression, not within health state mortality. They should not be considered an 
appropriate basis to facilitate reimbursement decisions.
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Objectives: This study evaluated the psychometric properties of the Brief Pain 
Inventory-Short Form (BPI-SF) in patients with moderate-to-severe systemic lupus 
erythematosus (SLE). MethOds: Participants were recruited using a free electronic 
medication-monitoring service. Patients ≥ 18 years who self-reported a physician 
diagnosis of SLE (confirmed by medical record review) and active SLE demonstrated 
by a Systemic Lupus Activity Questionnaire (SLAQ) score of ≥ 11 (0-44 scale) were 
included. BPI-SF and SF-36 were administered in electronic format at baseline, week 
2, and week 12. Psychometric properties of the BPI-SF and items and domains were 
evaluated by standard statistical techniques. Results: A total of 122 patients were 
included. Cronbach’s alpha were > 0.9 for all BPI-SF items. Test-retest reliability of 
the BPI-SF showed a stable correlation for item #7 (Intraclass Correlation Coefficient 
0.79); all other items and domain correlations were > 0.5. The BPI-SF domain and 
global scores were moderately positively correlated to the SLAQ score (all correlations 
r> 0.4), but negatively correlated to the SF-36 Bodily Pain domain (r< -0.6). The BPI-SF 
domain and global scores were moderately negatively correlated to the SF-36 Physical 
Function domain and Physical Component scores, with low correlations between 
the pain severity domain and SF-36 Mental Component scores (r= -0.16). The BPI-SF 
item #3 (worst pain) was moderately positively correlated to the SLAQ score (r= 0.49). 
Patients who self-reported inactive or less active disease activity (SLAQ < 29) scored 
lower on domain and global scores (p< 0.05) and item #3 (p< 0.0001), compared to 
patients who self-reported active disease activity (SLAQ ≥ 29). The findings suggested 
all BPI-SF domain scores and item #3 were able to differentiate between patients with 
less severe or more severe pain. cOnclusiOns: Assessment of pain intensity, as 
measured by the BPI-SF, demonstrated validity and reliability in a sample of patients 
with SLE and may be used as a patient-reported outcome tool in clinical trials.
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